1 |
UNODC. World drug report 2022[R/OL]. (2022-11-28)[2023-07-30]. .
|
2 |
POKLIS J L, CLAY D J, POKLIS A. High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens[J]. J Anal Toxicol,2014,38(3):113-121. doi:10.1093/jat/bku005 .
|
3 |
郭震,徐多麒,张云峰,等. 超高效液相色谱串联质谱法同时快速检验血液中3种哌嗪类新型毒品[J].中国法医学杂志,2019,34(3):257-260. doi:10.13618/j.issn.1001-5728.2019.03.0011 .
|
|
GUO Z, XU D Q, ZHANG Y F, et al. Determination of BZP, TFMPP and mCPP in blood by ultra performance liquid chromatography-mass spectrometry[J]. Zhongguo Fayixue Zazhi,2019,34(3):257-260.
|
4 |
ARBO M D, BASTOS M L, CARMO H F. Piperazine compounds as drugs of abuse[J]. Drug Alcohol Depend,2012,122(3):174-185. doi:10.1016/j.drugalcdep.2011.10.007 .
|
5 |
朱娜,俞晨,花镇东,等. 哌嗪类新精神活性物质的质谱特征研究[J].质谱学报,2021,42(1):1-7. doi:10.7538/zpxb.2019.0161 .
|
|
ZHU N, YU C, HUA Z D, et al. Mass fragmentation characteristics of piperazine analogues[J]. Zhi-pu Xuebao,2021,42(1):1-7.
|
6 |
KATZ D P, DERUITER J, BHATTACHARYA D, et al. Benzylpiperazine: “A messy drug”[J]. Drug Alcohol Depend,2016,164:1-7. doi:10.1016/j.drugal cdep.2016.04.010 .
|
7 |
吴禹霖.我国新精神活性物质滥用已经呈现快速蔓延的态势[M]//张勇安. 国际禁毒蓝皮书:国际禁毒研究报告( 2020).北京:社会科学文献出版社,2020:153-154.
|
|
WU Y L. The abuse of new psychoactive substances in China has shown a rapid spread trend[M]// ZHANG Y A. Blue book of international drug control: Annual report on international drug control ( 2020). Beijing: Social Sciences Academic Press,2020:153-154.
|
8 |
毒品犯罪与对策研究中心. 我国管制毒品目录[DB/OL].(2021-06-26)[2023-07-15]. .
|
|
Research Center of Drug Crime and Countermeasure. China’s drug control catalogue[DB/OL]. (2021-06-26)[2023-07-15]. .
|
9 |
CRAIG N, CHATTERTON, GRAHAM R . et al. A case of fatal benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) toxicity[J]. Can Soc Forensic Sci J,2012,45(3):150-154. doi:10.1080/00085030.2012.10757188 .
|
10 |
WIKSTRÖM M, HOLMGREN P, AHLNER J. A2 (N-benzylpiperazine) a new drug of abuse in Sweden[J]. J Anal Toxicol,2004,28(1):67-70. doi:10.1093/jat/28.1.67 .
|
11 |
BARROSO M, COSTA S, DIAS M, et al. Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry[J]. J Chromatogr A,2010,1217(40):6274-6280. doi:10.1016/j.chroma.2010.08.001 .
|
12 |
SCHEP L J, SLAUGHTER R J, VALE J A, et al. The clinical toxicology of the designer “party pills” benzylpiperazine and trifluoromethylphenylpiperazine[J]. Clin Toxicol (Phila),2011,49(3):131-141. doi:10.3109/15563650.2011.572076 .
|
13 |
ANTIA U, LEE H S, KYDD R R, et al. Pharmacokinetics of ‘party pill’ drug N-benzylpiperazine (BZP) in healthy human participants[J]. Forensic Sci Int,2009,186(1/2/3):63-67. doi:10.1016/j.forsciint.2009.01.015 .
|
14 |
ANTIA U, TINGLE M D, RUSSELL B R. Metabolic interactions with piperazine-based ‘party pill’ drugs[J]. J Pharm Pharmacol,2009,61(7):877-882. doi:10.1211/jpp/61.07.0006 .
|
15 |
TSUTSUMI H, KATAGI M, MIKI A, et al. Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine[J]. J Chromatogr B,2005,819(2):315-322. doi:10.1016/j.jchromb.2005.02.016 .
|
16 |
廖林川. 法医毒物分析[M].5版.北京:人民卫生出版社,2016:28-59.
|
|
LIAO L C. Forensic toxicological analysis[M]. 5th ed. Beijing: People’s Medical Publishing House,2016:28-59.
|
17 |
Dissociation constants of organic acids and bases[Z/OL]. (2016-07-16)[2023-07-30]. .
|
18 |
沈敏,向平. 毛发分析基础及应用[M].2版.北京:科学出版社,2020:3.
|
|
SHEN M, XIANG P. Fundamentals and applications of hair analysis[M]. 2nd ed. Beijing: Science Press,2020:3.
|
19 |
PETERS F T, SCHAEFER S, STAACK R F, et al. Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry[J]. J Mass Spectrom,2003,38(6):659-676. doi:10.1002/jms.483 .
|
20 |
STAACK R F, PAUL L D, SCHMID D, et al. Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake — Use as adulterant of cocaine resulting in drug-drug interactions?[J]. J Chromatogr B,2007,855(2):127-133. doi:10.1016/j.jchromb.2007.05.017 .
|
21 |
VORCE S P, HOLLER J M, LEVINE B, et al. Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS[J]. J Anal Toxicol,2008,32(6):444-450. doi:10.1093/jat/32.6.444 .
|
22 |
TSUTSUMI H, KATAGI M, MIKI A, et al. Metabolism and the urinary excretion profile of the recently scheduled designer drug N-benzylpiperazine (BZP) in the rat[J]. J Anal Toxicol,2006,30(1):38-43. doi:10.1093/jat/30.1.38 .
|
23 |
WADA M, YAMAHARA K, IKEDA R, et al. Simultaneous determination of N-benzylpiperazine and 1-(3-trifluoromethylphenyl)piperazine in rat plasma by HPLC-fluorescence detection and its application to monitoring of these drugs[J]. Biomed Chromatogr,2012,26(1):21-25. doi:10.1002/bmc.1619 .
|
24 |
ANTIA U, TINGLE M D, RUSSELL B R. Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans[J]. J Forensic Sci,2010,55(5):1311-1318. doi:10.1111/j.1556-4029.2010.01457.x .
|
25 |
BASSINDALE T A, BEREZOWSKI R. Quantitative analysis of hair samples for 1-benzylpiperazine (BZP) using high-performance liquid chromatography triple quadrupole mass spectrometry (LC-MS/MS) detection[J]. Anal Bioanal Chem,2011,401(6):2013-2017. doi:10.1007/s00216-011-5235-5 .
|
26 |
WOHLFARTH A, WEINMANN W, DRESEN S. LC-MS/MS screening method for designer amphe-tamines, tryptamines, and piperazines in serum[J]. Anal Bioanal Chem,2010,396(7):2403-2414. doi:10.1007/s00216-009-3394-4 .
|
27 |
BALMELLI C, KUPFERSCHMIDT H, RENTSCH K, et al. Fatal brain edema after ingestion of ecstasy and benzylpiperazine[J]. Dtsch Med Wochenschr,2001,126(28/29):809-811. doi:10.1055/s-2001-15702 .
|
28 |
AUSTIN H, MONASTERIO E. Acute psychosis following ingestion of ‘Rapture’[J]. Australas Psychiat,2004,12(4):406-408. doi:10.1111/j.1440-1665. 2004.02137.x .
|
29 |
KOVALEVA J, IR E D, DE PAEPE P, et al. Acute chlorophenylpiperazine overdose: A case report and review of the literature[J]. Ther Drug Monit,2008,30(3):394-398. doi:10.1097/ftd.0b013e318170a879 .
|
30 |
WOOD D M, BUTTON J, LIDDER S, et al. Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP)[J]. J Med Toxicol,2008,4(4):254-257. doi:10.1007/BF03161209 .
|
31 |
GEE P, JERRAM T, BOWIE D. Multiorgan failure from 1-benzylpiperazine ingestion — Legal high or lethal high?[J]. Clin Toxicol (Phila),2010,48(3):230-233. doi:10.3109/15563651003592948 .
|
32 |
GEE P, RICHARDSON S, WOLTERSDORF W, et al. Toxic effects of BZP-based herbal party pills in humans: A prospective study in Christchurch, New Zealand[J]. N Z Med J,2005,118(1227):U1784.
|